Scapula Retraction Exercises in Subacromial Pain Syndrome

February 10, 2024 updated by: Leyla Eraslan, Hacettepe University

Investigating the Effect of Scapula Retraction Exercises on Acromiohumeral Distance Values and Symptoms (Pain and Disability) in Patients With SPS

Scapula retraction exercises are often recommended as a part of the exercise programs. The primary aim of this study is to investigate the initial effect of the scapula retraction exercises on acromiohumeral distance (AHD) at varying shoulder abduction angles and to compare asymptomatic subjects. The secondary aim of this study is to investigate the effect of scapula retraction exercises on AHD values and symptoms (pain and disability) in patients with SPS.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Subacmial pain syndrome (SPS) is a common cause of shoulder pain and dysfunction in the general population. Exercise interventions is thought as a primary choice in clinical settings. Scapula retraction exercises are commonly recommended as a part of the exercise programs. Applying scapula retraction exercises at varying shoulder abduction angles could restore balance between the scapulothoracic muscles. Since the scapulothoracic muscles dynamically control subacromial space, scapula retraction exercises could further help to maintain AHD during arm elevation.

The primary aim of this study is to investigate the initial effect of the scapula retraction exercises on acromiohumeral distance (AHD) at varying shoulder abduction angles and to compare asymptomatic subjects. The secondary aim of this study is to investigate the effect of scapula retraction exercises on AHD values and symptoms (pain and disability) in patients with SPS.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06100
        • Hacettepe University, Faculty of Physical Therapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Inclusion Criteria:

  • aged between 18-45
  • painful arc of movement during flexion or abduction;
  • positive Neer or Kennedy-Hawkins impingement signs
  • pain on resisted lateral rotation, abduction or empty can test.

Exclusion Criteria:

  • previous shoulder surgery;
  • shoulder pain reproduced by neck movement;
  • clinical signs of full-thickness RC tears; or
  • adhesive capsulitis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group

exercise program consists of progressive scapula retraction exercises will be applied three times a week total 24 sessions.

Home exercise program will also advised two times a day.

Scapula retraction exercises at varying shoulder abduction angles will be applied
No Intervention: Control Group
Control group will not perform scapula retraction exercises. AHD values of the control group will be compared to intervention groups both retracted and non-retracted conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acromiohumeral Distance (AHD) measurement
Time Frame: Acromiohumeral distance values will be recorded at baseline and 8-week follow-up
Acromiohumeral Distance will be recorded at 0°, 30°, 45°, 60° and 90° of shoulder abduction, and while they are doing scapular retraction with resistive elastic band at each shoulder position. All assessment will be recorded at baseline and at the end of the eight week rehabilitation sessions
Acromiohumeral distance values will be recorded at baseline and 8-week follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain severity
Time Frame: pain severity will be recorded at baseline and 8-week follow-up

pain severity will be assessed by using 100 millimeters Visual Analogue Scale at rest, at night and during activity.

All patients were asked to mark their pain level that corresponds to their pain intensity on the line between "0=no pain" and "100=the worst pain imaginable".

pain severity will be recorded at baseline and 8-week follow-up
disability status
Time Frame: PADI Score will be recorded at baseline and 8-week follow-up

disability status will be assessed by using Shoulder Pain and Disability Index (SPADİ). All assessment will be recorded at baseline and at the end of the eight week treatment sessions.

The questionnaire is scored on a 100-point scale, where 0 represents "no disabilities" and 100 represents "extreme disabilities"

PADI Score will be recorded at baseline and 8-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2021

Primary Completion (Actual)

October 30, 2022

Study Completion (Actual)

June 17, 2023

Study Registration Dates

First Submitted

June 29, 2021

First Submitted That Met QC Criteria

July 8, 2021

First Posted (Actual)

July 9, 2021

Study Record Updates

Last Update Posted (Actual)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 10, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Impingement Syndrome

Clinical Trials on Exercise Intervention

Subscribe